Successful pregnancy and lactation outcome in a patient with Gaucher disease receiving enzyme replacement therapy, and the subsequent distribution and excretion of imiglucerase in human breast milk

Clinical Therapeutics

Volumn 32, Issue 12, 2010, Pages 2048-2052

  Sekijima, Yoshiki ^a,b   Ohashi, Toya ^c   Ohira, Satoshi ^b   Kosho, Tomoki ^a   Fukushima, Yoshimitsu ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Enzyme replacement therapy; Gaucher disease; Glucocerebrosidase; Human milk; Imiglucerase; Lactation

Indexed keywords

BETA GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDASE; IMIGLUCERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CASE REPORT; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG MILK LEVEL; ENZYME ACTIVITY; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; HUMAN; LACTATION; PREGNANCY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; ENZYME REPLACEMENT THERAPY; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; INFUSIONS, INTRAVENOUS; LACTATION; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 78649552894     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.11.008     Document Type: Article

References (18)

1. Beutler E, Grabowski GA Gaucher disease. The Metabolic and Molecular Bases of Inherited Diseases 2001, Vol III:3635-3668. McGraw-Hill, New York, NY. C.R. Scriver, D. Valle, A. Beudet, W.S. Sly (Eds.).
2. Barton NW, Brady RO, Dambrosia JM, et al. Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med. 1991, 324:1464-1470.
3. Grabowski GA, Barton NW, Pastores G, et al. Enzyme therapy in type 1 Gaucher disease: Comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med. 1995, 122:33-39.
4. Weinreb NJ, Charrow J, Andersson HC, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: A re- port from the Gaucher Registry. Am J Med. 2002, 113:112-119.
5. Sims KB, Pastores GM, Weinreb NJ, et al. Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher dis- ease: Results of a 48-month longitudinal cohort study. Clin Genet. 2008, 73:430-440.
6. Cerezyme® (imiglucerase for injection) [package insert] 2005, Genzyme Corporation, Cambridge, Mass.
7. Tanaka N, Saito H, Ito T, et al. Initiation of enzyme replace- ment therapy for an adult patient with asymptomatic type 1 Gaucher's disease. Intern Med. 2001, 40:716-721.
8. Elstein D, Granovsky-Grisaru S, Rabinowitz R, et al. Use of enzyme replacement therapy for Gaucher disease during pregnancy. Am J Obstet Gynecol. 1997, 177:1509-1512.
9. Elstein Y, Eisenberg V, Granovsky-Grisaru S, et al. Pregnancies in Gaucher disease: A 5-year study. Am J Obstet Gynecol. 2004, 190:435-441.
10. Pastores GM, Weinreb NJ, Aerts H, et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol. 2004, 41(Suppl 5):4-14.
11. Weinreb NJ, Aggio MC, Andersson HC, et al. Gaucher disease type 1: Revised recommendations on evaluations and monitoring for adult patients [published correction appears in Semin Hematol. 2005;42:179]. Semin Hematol 2004, 41(Suppl 5):15-22. International Collaborative Gaucher Group.
12. Andersson HC, Charrow J, Kaplan P, et al. Individualization of long-term enzyme replacement therapy for Gaucher disease. Genet Med. 2005, 7:105-110. International Collabor- ative Gaucher Group US Regional Coordinators.
13. Zimran A, Morris E, Mengel E, et al. The female Gaucher patient: The impact of enzyme replacement ther- apy around key reproductive events (menstruation, pregnancy and menopause). Blood Cells Mol Dis. 2009, 43:264-288.
14. Cox TM, Aerts JM, Belmatoug N, et al. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis. 2008, 31:319-336.
15. Mrsić M, Fumić K, Vrćić H, et al. Successful pregnancy on enzyme replacement therapy with cerezyme. Clin Ther. 2007, 29(Suppl C):S84-S85.
16. Brady RO, Kanfer J, Shapiro D The metabolism of glucocerebrosides. I. Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue. J Biol Chem. 1965, 240:39-43.
17. Kalkwarf HJ, Specker BL Bone mineral changes during pregnancy and lactation. Endocrine. 2002, 17:49-53.
18. Newton ER Breast milk: The gold standard. Clin Obstet Gynecol. 2004, 47:632-642.